Core Viewpoint - Haohai Biological Technology announced a share reduction plan by shareholder Mr. Lou Guoliang due to personal financial needs, intending to reduce up to 1.5 million shares, representing no more than 0.6432% of the company's total share capital of 233 million shares [1] Summary by Sections - Share Reduction Plan - Mr. Lou Guoliang plans to reduce his holdings through centralized bidding and block trading, with a total reduction not exceeding 1.5 million shares [1] - The reduction will occur within three months after the announcement date, starting from three trading days post-announcement [1] - Reduction Details - The maximum reduction through centralized bidding is capped at 1.5 million shares, with the same limit for block trading [1] - The reduction price will be determined based on the secondary market price [1] - Reduction Outcome - As of September 29, 2025, Mr. Lou Guoliang has reduced his holdings by 1.4914 million shares through centralized bidding, which is approximately 0.6413% of the current total share capital [1]
昊海生物科技(06826)：楼国梁已累计减持公司股份149.14万股